0000000000186652

AUTHOR

Julio Pascual

showing 6 related works from this author

Validity and reliability of the Migraine-Treatment Optimization Questionnaire.

2009

Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSSQoL)]. A 15-item (M-TOQ15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were iden…

AdultMalemedicine.medical_specialtyMigraine DisordersValidityDisability EvaluationQuality of lifeCronbach's alphaSurveys and QuestionnairesOutcome Assessment Health CareMedicineHumansMigraine treatmentAgedbusiness.industryConstruct validityReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseTolerabilityMigrainePhysical therapyQuality of LifeInternational Classification of Headache DisordersFemaleNeurology (clinical)businessClinical psychologyCephalalgia : an international journal of headache
researchProduct

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan’s Efficacy:

2021

n/a.

Oncologymedicine.medical_specialtyMEDLINEeGFR declineType 2 diabetesEgfr declineendothelin receptor antagonistlaw.inventionRandomized controlled triallawInternal medicinePost-hoc analysismedicinebusiness.industryEndothelin receptor antagonistAtrasentan22/2 OA procedureGeneral Medicinemedicine.diseaseClinical trialNephrologyrandomized controlled trialtype 2 diabetesbusinesschronic kidney diseasemedicine.drugJournal of the American Society of Nephrology
researchProduct

Efficacy of Therapeutic Intervention in Headache Units in Patients With Frequent Headaches: The EFUNCE Study

2006

Data confirming that therapeutic intervention in headache units is superior to care received by patients in other levels of the health system are scant. This is a pilot study that includes patients seen in 4 headache units for at least 1 year, who had a headache frequency of more than 15 days per month. The results of the first 30 patients showed a significant improvement in different headache parameters and a high degree of satisfaction with the treatment received.

AdultMalePediatricsmedicine.medical_specialtyQuality Assurance Health CarePilot ProjectsAmbulatory Care FacilitiesPatient satisfactionFrequent headachesQuality of lifeIntervention (counseling)HumansMedicineIn patientRetrospective Studiesbusiness.industryHeadacheRetrospective cohort studyMiddle AgedNeurologyPatient SatisfactionQuality of LifePhysical therapyMedicineFemaleNeurology (clinical)businessProgram EvaluationSpecializationHeadache: The Journal of Head and Face Pain
researchProduct

The FRAILMar Study Protocol: Frailty in Patients With Advanced Chronic Kidney Disease Awaiting Kidney Transplantation. A Randomized Clinical Trial of…

2021

Introduction: Frailty is very frequent among patients with chronic kidney disease (CKD) who are awaiting deceased donor kidney transplantation (KT), and transplant outcomes are worsened in those frail recipients. Frailty and poor fitness powerfully predict mortality, kidney graft survival, and healthcare utilization after KT. Intervention is essential to improve survival and quality of life for frail CKD patients, regardless of their age. Studies of post-transplant physical therapy intervention have been met with limited success, in large part due to high dropout rates. A pre-transplant clinical framework for multimodal prehabilitation interventions including physical therapy, nutritional m…

Medicine (General)medicine.medical_specialtyPrehabilitationlaw.inventionKidney transplantationStudy ProtocolR5-920Quality of lifeRandomized controlled triallawChronic kidney diseaseClinical endpointMedicineExerciseKidney transplantationNutritionFrailtybusiness.industryGeneral Medicinemedicine.diseaseTransplantationClinical trialPhysical therapyMedicinebusinessPrehabilitaionKidney disease
researchProduct

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

2016

Appropriate post-transplant immunosuppressive regimens that avoid acute rejection, while reducing risk of viral reactivation, have been sought, but remain a chimera. Recent evidence suggesting potential regulatory and antiviral effects of mammalian target of rapamycin inhibitors (mTORi) is of great interest. Although the concept of an immunosuppressive drug with antiviral properties is not new, little effort has been made to put the evidence together to assess the management of immunosuppressive therapy in the presence of a viral infection. This review was developed to gather the evidence on antiviral activity of the mTORi against the viruses that most commonly reactivate in adult solid org…

Graft Rejectionmedicine.medical_specialtymedicine.medical_treatmentHepatitis C virus030230 surgerymedicine.disease_causeAntiviral AgentsOrgan transplantationVirus03 medical and health sciencesChimera (genetics)0302 clinical medicinemedicineHumansImmunosuppression TherapyTransplantationEverolimusbusiness.industryTOR Serine-Threonine Kinasesvirus diseasesImmunosuppressionOrgan TransplantationTransplant RecipientsInfectious DiseasesImmunosuppressive drugVirus DiseasesSirolimusImmunology030211 gastroenterology & hepatologybusinessImmunosuppressive Agentsmedicine.drugTransplant Infectious Disease
researchProduct

Antiepileptic Drugs for the Treatment of Chronic and Episodic Cluster Headache: A Review.

2007

Cluster headache needs to be rapidly diagnosed and effectively managed, as the individual headache attacks that are characteristic of this disorder are excruciatingly painful and debilitating. Preventive therapies are necessary to reduce the frequency of attacks during the cluster period. However, preventive therapy for this disorder is limited by a lack of controlled evidence of efficacy and the potential for systemic toxicity. Recent progress has been made in understanding both the pathophysiological mechanisms underlying cluster headache and the mechanisms of action of the antiepileptic drug class for the treatment of primary headache syndromes. Newly available preliminary clinical trial…

Topiramatemedicine.medical_specialtyCyclohexanecarboxylic AcidsGabapentinmedicine.drug_classCluster HeadacheFructoseNeurological disorderDisease clusterReceptors GABATopiramatemedicineHumansAminesIntensive care medicinegamma-Aminobutyric AcidValproic Acidbusiness.industryValproic AcidCluster headacheMood stabilizermedicine.diseaseClinical trialTreatment OutcomeNeurologyAnesthesiaAnticonvulsantsNeurology (clinical)Gabapentinbusinessmedicine.drugHeadache: The Journal of Head and Face Pain
researchProduct